Zhengye Biotechnology Holding ZYBT
NASDAQ ZYBT
$1.52 -0.02 (-1.30%)
As of: Nov 11, 2026 · 3:58 PM EST

Zhengye Biotechnology Holding (ZYBT) Total Liabilities (2023 - 2025)

Updated

Zhengye Biotechnology Holding (ZYBT) recorded Total Liabilities of $18.29 million in the quarter ended Dec 31, 2025, down 6.6% from $19.59 million a year earlier.

Analysis

Zhengye Biotechnology Holding (ZYBT) Total Liabilities (2023 - 2025) Analysis & Trends

As of Dec 31, 2025, Zhengye Biotechnology Holding reported Total Liabilities of $18.06 million, down 7.8% from the prior year.

  • Across earlier years, Total Liabilities came in at $19.58 million in the year ended Dec 31, 2024 (-13.8%) and $22.73 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 107.80 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 115.90 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 152.26 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 87.83 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 68.11 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 81.70 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 38.37 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 115.70 Bn
10 Zhengye Biotechnology Holding 72.98 Mn 69.39 Mn - 18.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 18.55 Mn
Jun 30, 2025 19.48 Mn
Dec 31, 2024 19.28 Mn
Dec 31, 2023 22.60 Mn
API Access

Zhengye Biotechnology Holding Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=ZYBT&period=max&api_key=YOUR_API_KEY